Signal2026-07-28
ClinicalTrials.gov

[PHASE1] BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

Part of

Early Phase Immune Therapeutics Trials

Open primary sourceSee the whole picture